Literature DB >> 19854157

Tumor suppressor CADM1 is involved in epithelial cell structure.

Mika Sakurai-Yageta1, Mari Masuda, Yumi Tsuboi, Akihiko Ito, Yoshinori Murakami.   

Abstract

The tumor suppressor, CADM1, is involved in cell adhesion and preferentially inactivated in invasive cancer. We have previously reported that CADM1 associates with an actin-binding protein, 4.1B/DAL-1, and a scaffold protein, membrane protein palmitoylated 3 (MPP3)/DLG3. However, underlying mechanism of tumor suppression by CADM1 is not clarified yet. Here, we demonstrate that MPP1/p55 and MPP2/DLG2, as well as MPP3, interact with both CADM1 and 4.1B, forming a tripartite complex. We then examined cell biological roles of CADM1 and its complex in epithelia using HEK293 cells. Among MPP1-3, MPP2 is recruited to the CADM1-4.1B complex in the early process of adhesion in HEK293 cells. By suppression of CADM1 expression using siRNA, HEK293 lose epithelia-like structure and show flat morphology with immature cell adhesion. 4.1B and MPP2, as well as E-cadherin and ZO-1, are mislocalized from the membrane by depletion of CADM1 in HEK293. Mislocalization of MPP2 is also observed in several cancer cells lacking CADM1 expression with the transformed morphology. These findings suggest that CADM1 is involved in the formation of epithelia-like cell structure with 4.1B and MPP2, while loss of its function could cause morphological transformation of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854157     DOI: 10.1016/j.bbrc.2009.10.088

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

Review 1.  Biological glass: structural determinants of eye lens transparency.

Authors:  Steven Bassnett; Yanrong Shi; Gijs F J M Vrensen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-04-27       Impact factor: 6.237

2.  Membrane palmitoylated proteins regulate trafficking and processing of nectins.

Authors:  Amanda Dudak; Jinsook Kim; Bryan Cheong; Howard J Federoff; Seung T Lim
Journal:  Eur J Cell Biol       Date:  2011-03-02       Impact factor: 4.492

3.  Extracellular CADM1 interactions influence insulin secretion by rat and human islet β-cells and promote clustering of syntaxin-1.

Authors:  Charles Zhang; Thomas A Caldwell; M Reza Mirbolooki; Diana Duong; Eun Jee Park; Nai-Wen Chi; Steven D Chessler
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-04-12       Impact factor: 4.310

Review 4.  Tumor suppressor role of protein 4.1B/DAL-1.

Authors:  Zi Wang; Ji Zhang; Mao Ye; Min Zhu; Bin Zhang; Mridul Roy; Jing Liu; Xiuli An
Journal:  Cell Mol Life Sci       Date:  2014-09-03       Impact factor: 9.261

5.  Cadm1 expression and function in the mouse lens.

Authors:  Alicia De Maria; Yanrong Shi; Xianmin Luo; Louise Van Der Weyden; Steven Bassnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-08       Impact factor: 4.799

6.  MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells.

Authors:  Qing-jun Li; Liang Zhou; Fan Yang; Guo-xia Wang; Hang Zheng; De-sheng Wang; Yong He; Ke-feng Dou
Journal:  Tumour Biol       Date:  2012-04-18

7.  Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer.

Authors:  Guimin Chang; Shuping Xu; Rajiv Dhir; Uma Chandran; Denise S O'Keefe; Norman M Greenberg; Jeffrey R Gingrich
Journal:  Clin Cancer Res       Date:  2010-11-09       Impact factor: 12.531

8.  Tumor suppressor in lung cancer-1 (TSLC1) mediated by dual-regulated oncolytic adenovirus exerts specific antitumor actions in a mouse model.

Authors:  Wen Lei; Hong-bin Liu; Shi-bing Wang; Xiu-mei Zhou; Shui-di Zheng; Ke-ni Guo; Bu-yun Ma; Yu-long Xia; Wen-song Tan; Xin-yuan Liu; Yi-gang Wang
Journal:  Acta Pharmacol Sin       Date:  2013-03-18       Impact factor: 6.150

9.  Genetic variants in Cell Adhesion Molecule 1 (CADM1): a validation study of a novel endothelial cell venous thrombosis risk factor.

Authors:  Hugoline G de Haan; Irene D Bezemer; Carla Y Vossen; Astrid van Hylckama Vlieg; Stefan Böehringer; Sandra J Hasstedt; Samuel Levy; Frits R Rosendaal; Edwin G Bovill
Journal:  Thromb Res       Date:  2014-09-23       Impact factor: 3.944

10.  Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism.

Authors:  Huensuk Kim; Seungyeul Yoo; Ruoji Zhou; An Xu; Jeffrey M Bernitz; Ye Yuan; Andreia M Gomes; Michael G Daniel; Jie Su; Elizabeth G Demicco; Jun Zhu; Kateri A Moore; Dung-Fang Lee; Ihor R Lemischka; Christoph Schaniel
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.